Clinical Trial Update: Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial compares neoadjuvant gemcitabine and cisplatin with perioperative pembrolizumab versus upfront surgery in patients with primary resec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Cholangiocarcinoma
• Extrahepatic Cholangiocarcinoma
• Perihilar Cholangiocarcinoma

Drugs mentioned

• Gemzar (gemcitabine) (gemcitabine)
• Keytruda (Pembrolizumab) (pembrolizumab)
• Platinol (Cisplatin) (Cisplatin)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Extrahepatic Cholangiocarcinoma, Perihilar Cholangiocarcinoma | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING